Tanguay J, Callahan K, DAvanzo N
Sci Rep. 2019; 9(1):465.
PMID: 30679654
PMC: 6345760.
DOI: 10.1038/s41598-018-37116-2.
Lakatta E, DiFrancesco D
J Mol Cell Cardiol. 2009; 47(2):157-70.
PMID: 19361514
PMC: 4554526.
DOI: 10.1016/j.yjmcc.2009.03.022.
DiFrancesco D, Borer J
Drugs. 2007; 67 Suppl 2:15-24.
PMID: 17999560
DOI: 10.2165/00003495-200767002-00003.
Fliss G, Staab A, Tillmann C, Trommeshauser D, Schaefer H, Kloft C
Pharm Res. 2007; 25(2):359-68.
PMID: 17587152
DOI: 10.1007/s11095-007-9351-z.
Arndts D, Warnkross H, ROMINGER K, Justus H
Eur J Clin Pharmacol. 1981; 21(3):201-7.
PMID: 7318879
DOI: 10.1007/BF00627921.
Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.
Arndts D, Leb G, Forster H
Eur J Drug Metab Pharmacokinet. 1981; 6(3):225-36.
PMID: 7308242
DOI: 10.1007/BF03189492.
Proceedings of the British Pharmacological Society. 16--18th December, 1980.
Br J Pharmacol. 1981; 73(1):175P-318P.
PMID: 7284696
PMC: 2071855.
DOI: 10.1111/j.1476-5381.1981.tb16787.x.
Systemic and regional myocardial responses to AR-L 115 BS, a positive inotropic imidazo-pyridine, in the absence or in the presence of the bradycardiac action of alinidine.
Verdouw P, Hartog J, Ruggeman A
Basic Res Cardiol. 1981; 76(3):328-43.
PMID: 7271723
DOI: 10.1007/BF01907776.
The effects of the bradycardia-producing compound alinidine on action potentials and tension development in cardiac fibres.
Tritthart H, Windisch H, Heuberger S
Naunyn Schmiedebergs Arch Pharmacol. 1981; 316(2):172-7.
PMID: 7242703
DOI: 10.1007/BF00505313.
Alinidine pharmacokinetics following acute and chronic dosing.
Harron D, Arndts D, Shanks R
Br J Clin Pharmacol. 1982; 13(6):821-7.
PMID: 7093113
PMC: 1402022.
DOI: 10.1111/j.1365-2125.1982.tb01873.x.
The effect of alinidine (St 567) on emotionally induced tachycardia in man.
Aubock J, KONZETT H, Olbrich E
Eur J Clin Pharmacol. 1982; 21(6):467-71.
PMID: 7075652
DOI: 10.1007/BF00542040.
Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.
Nicholls D, Harron D, Shanks R
Br J Clin Pharmacol. 1983; 15(1):21-9.
PMID: 6849740
PMC: 1427818.
DOI: 10.1111/j.1365-2125.1983.tb01458.x.
Acute effects of alinidine on heart rate and blood pressure in healthy subjects and patients with hyperkinetic heart syndrome.
Stanek B, Reiterer W, Placheta P, Raberger G
Eur J Clin Pharmacol. 1983; 24(1):31-4.
PMID: 6832198
DOI: 10.1007/BF00613923.
Comparative effects of alinidine and propranolol in ischaemic heart disease.
Schurmans J, Piessens J, Kesteloot H, De Geest H
Eur J Clin Pharmacol. 1982; 23(5):389-96.
PMID: 6759144
DOI: 10.1007/BF00605987.
An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine.
Harron D, Arndts D, Finch M, Shanks R
Br J Clin Pharmacol. 1983; 16(4):451-5.
PMID: 6626441
PMC: 1428036.
DOI: 10.1111/j.1365-2125.1983.tb02196.x.
Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
Nicholls D, McNeill J, OConnor P, Harron D, Leahey W, Shanks R
Br J Clin Pharmacol. 1984; 18(2):215-21.
PMID: 6386022
PMC: 1463526.
DOI: 10.1111/j.1365-2125.1984.tb02455.x.
Blood level, distribution, metabolite pattern and excretion of [14C]alinidine in mice and rats.
Bechtel W, Richter I
Eur J Drug Metab Pharmacokinet. 1986; 11(3):175-86.
PMID: 3816873
DOI: 10.1007/BF03189845.
Alinidine modifies the pacemaker current in sheep Purkinje fibers.
Snyders D, Van Bogaert P
Pflugers Arch. 1987; 410(1-2):83-91.
PMID: 3684510
DOI: 10.1007/BF00581900.
Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.
Krumpl G, Winkler M, Schneider W, Raberger G
Br J Pharmacol. 1988; 94(1):55-64.
PMID: 3401644
PMC: 1853935.
DOI: 10.1111/j.1476-5381.1988.tb11499.x.
Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.
Boucher M, Chapuy E, Lefebvre M, Mignot A, DUCHENE-MARULLAZ P
Naunyn Schmiedebergs Arch Pharmacol. 1989; 339(6):630-7.
PMID: 2570365
DOI: 10.1007/BF00168655.
